Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for Beta-Amyloid Imaging in Aging and Dementia

Trial Profile

Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for Beta-Amyloid Imaging in Aging and Dementia

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2016

At a glance

  • Drugs Flutafuranol F 18 (Primary) ; Pittsburgh compound B
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Most Recent Events

    • 19 Oct 2015 New trial record
    • 23 Jul 2015 Results presented at the 2015 Alzheimer's Association International Conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top